Deferiprone structure
Deferiprone
Deferiprone is the only orally active iron-chelating drug to be used therapeutically in conditions of transfusional iron overload. Target：Deferiprone is an orphan drug designed and developed primarily by academic initiatives for the treatment of iron overload in thalassaemia. Deferiprone has been used in several other iron or other metal imbalance conditions and has prospects of wider clinical applications. Deferiprone has high affinity for iron and interacts with almost all the iron poo
Find 11 Related Holders
HeBei Guolong Pharmaceutical Co., Ltd.
China
China
API Registration Country
API Inactive
-
Founded in:
2011-01-28 -
Country:
China -
Address:
No. 9 Xingye Street, Shijiazhuang Economic and Technological Development Zone, Hebei Province -
Tax NO.:
911301005689263244 -
Registered Funds:
450 million yuan -
Email:
Recommended Suppliers of Deferiprone
-
Greenbo Biochem
CN1 YR
Contact Supplier -
Shandong Airuike Chemical Co., Ltd.
CN1 YR
Contact Supplier -
Amitychem
CN1 YR
Contact Supplier -
GIHI CHEMICALS CO.,LIMITED
CN1 YR
Contact Supplier -
HANGZHOU LEAP CHEM CO., LTD.
CN1 YR
Contact Supplier